Genoa's series A brings in $62M

Pulmonary play Genoa Pharmaceuticals Inc. (Seattle, Wash.) raised $62 million in a series A round on May 15 led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Also participa...